Afya (NASDAQ:AFYA) Hits New 12-Month Low – Time to Sell?

Afya Limited (NASDAQ:AFYA – Get Free Report) shares reached a new 52-week low on Friday. The stock traded as low as $9.52 and last traded at $9.7050, with a volume of 15,048 shares traded. The stock had previously closed at $10.15.

Analyst Upgrades and Downgrades

AFYA has been the subject of several research analyst reports. Bradesco Corretora raised shares of Afya to an “outperform” rating and set a $17.00 price target for the company in a report on Thursday, September 24th. JPMorgan Chase & Co. reduced their target price on Afya from $19.00 to $17.50 and set an “overweight” rating on the stock in a report on Tuesday, November 3rd. Wall Street Zen lowered Afya from a “buy” rating to a “hold” rating in a report on Monday. Weiss Ratings cut Afya from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Thursday, October 29th. Finally, Citigroup upgraded Afya from a “neutral” rating to a “buy” rating and lowered their price target for the stock from $16.00 to $12.00 in a report on Tuesday, November 3rd. Four research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and two have given a Sell rating to the company. According to MarketBeat, Afya currently has a consensus rating of “Hold” and a consensus price target of $15.18.

Get Our Latest Stock Report on Afya

Afya Stock Performance

The company has a debt-to-equity ratio of 0.38, a current ratio of 2.08 and a quick ratio of 2.08. The stock’s 50 day simple moving average is $12.50 and its two-hundred day simple moving average is $13.90. The stock has a market cap of $905.34 million, a P/E ratio of 5.68, a price-to-earnings-growth ratio of 1.63 and a beta of 0.43.

Insider Activity

In related news, insider Santos Welder Ferreira sold 4,161 shares of the firm’s stock in a transaction on Monday, October 5th. The shares were sold at an average price of $13.30, for a total transaction of $55,341.30. Following the sale, the insider directly owned 35,000 shares in the company, valued at $465,500. This trade represents a 10.63% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 0.80% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Afya

A number of institutional investors and hedge funds have recently added to or reduced their stakes in AFYA. Goldman Sachs Group Inc. bought a new stake in shares of Afya in the third quarter valued at about $1,043,000. Dodge & Cox boosted its position in shares of Afya by 33.5% during the third quarter. Dodge & Cox now owns 68,487 shares of the company’s stock worth $825,000 after buying an additional 17,200 shares during the period. Entropy Technologies LP bought a new position in shares of Afya during the third quarter worth about $246,000. Jump Financial LLC bought a new position in shares of Afya during the third quarter worth about $819,000. Finally, Marshall Wace LLP acquired a new stake in Afya in the 3rd quarter valued at approximately $399,000. 88.02% of the stock is owned by institutional investors and hedge funds.

Afya Company Profile

(Get Free Report)

Afya Limited is a Brazilian medical education and digital health company. Its education business offers undergraduate medical degree programs, medical residency preparation, postgraduate courses and continuing education for health professionals. The company also provides digital tools and services for medical students and practicing physicians, including clinical reference, practice-management and learning resources. These offerings support professionals at different stages of their medical careers.

See Also

Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.